CatalystFDA/Bio

Genmab: Epkinly Shines In Phase 3 DLBCL Trial

Positive Phase 3 DLBCL trial results for Genmab's Epkinly drive the score.

What changed

Positive Phase 3 DLBCL trial results for Genmab's Epkinly drive the score.

Why it matters

Positive Phase 3 DLBCL trial results for Genmab's Epkinly drive the score. — impact context not separately stored; see What changed.

Sources